HAE International, a global nonprofit that supports local hereditary angioedema (HAE) patient groups and organizations, has expanded their…
Bionews Staff
Bionews, the owner and publisher of this site, employs science writers and editors, most of whom have PhDs in the life sciences, as well as veteran journalists, who ensure stories are well-written and easy to understand. Our stories undergo a comprehensive fact-checking and editing process to confirm accuracy, objectiveness, and thoroughness in order to best serve our audience of patients and caregivers.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Bionews Staff
The U.S. Patent and Trademark Office (USPTO) issued a new allowance for a patent submitted by BioCryst Pharmaceuticals…
The Committee for Medicinal Products for Human Use (CHMP), part of the European Medicines Agency (EMA), is recommending…
FFF Enterprises and Bionews announced today that both rare and orphan disease advocates are joining forces to provide patients with…
Study Identifies Treatments That Reduce Acute Attacks in HAE Patients With Plasminogen Mutation
People with hereditary angioedema (HAE) caused by a specific mutation in the plasminogen gene have several on-demand and…
A new diagnostic tool has been identified for people with hereditary angiodema (HAE) and normal C1 inhibitor activity,…
Use of ACE inhibitors to treat high blood pressure can sometimes cause swelling (angioedema) episodes, but the prevalence of this…
Study Identifies Risk Factors That May Predispose Children to More Severe Initial Angioedema Attacks
Researchers have identified risk factors that may predispose children to more severe initial angioedema attacks — factors such as male…